获取途径

作者

Shen, Ming-Hung Chen, Ling-Ping Ho, Thien-Fiew Shih, Ying-Yih Huang, Ching-Shui Chie, Wei-Chu Huang, Chi-Cheng

作者单位

Gui-Zi Rd., Taishan Dist.243New Taipei CityTaiwan Division of Hematology and Oncology, Department of MedicineCathay General HospitalNo.280, Jen-I Rd. Sec.4, Daan Dist.106Taipei CityTaiwan Department of SurgeryCathay General Hospital SijhihNo.2, Lane 59, Jian-Cheng Rd., Sijhih Dist.221New Taipei CityTaiwan Department of MedicineCathay General Hospital SijhihNo.2, Lane 59, Jian-Cheng Rd., Sijhih Dist.221New Taipei CityTaiwan Division of General Surgery, Department of SurgeryCathay General HospitalNo.280, Jen-I Rd. Sec.4, Daan Dist.106Taipei CityTaiwan School of Medicine, College of MedicineTaipei Medical UniversityNo.250, Wu-Xing St., Xinyi Dist.110Taipei CityTaiwan Institute of Epidemiology and Preventive Medicine, College of Public HealthNational Taiwan UniversityNo.17, Xu-Zhou Rd., Zhongzheng Dist.100Taipei CityTaiwan School of Medicine, College of MedicineFu-Jen Catholic UniversityNo.510, Zhong-Zheng Rd., Xinzhuang Dist.242New Taipei CityTaiwan Division of Colorectal Surgery, Department of SurgeryCathay General HospitalNo.280, Jen-I Rd. Sec.4, Daan Dist.106Taipei CityTaiwan Division of General Surgery, Department of SurgeryFu-Jen Catholic University HospitalNo.69

刊名

BMC Cancer (BMC CANCER)

年份

2018

卷号

Vol.18 No.1

页码

1

ISSN

1471-2407

摘要

Background: The increasing incidence of colorectal cancer in Taiwan has generated a need for a disease-specific quality-of-life measuring instrument. We aimed to validate the Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-CR29.Methods: A total of 108 patients were interviewed. Convergent and discriminant validity, Cronbach's alpha coefficient, test-retest reliability, and known-groups comparisons were used to examine the reliability and ...更多

Background: The increasing incidence of colorectal cancer in Taiwan has generated a need for a disease-specific quality-of-life measuring instrument. We aimed to validate the Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-CR29.Methods: A total of 108 patients were interviewed. Convergent and discriminant validity, Cronbach's alpha coefficient, test-retest reliability, and known-groups comparisons were used to examine the reliability and validity.Results: We found good internal consistency reliability for multi-item scales of the QLQ-C30 and QLQ-CR29, except for the cognitive function and pain scale of the QLQ-C30. Patients in the active treatment group reported compromised functional scale scores and worse symptoms than those in the follow-up group. Similar results were found in comparisons based on Eastern Cooperative Oncology Group Performance Status and Bristol Stool Scale: higher physical function/sexual interest, less fatigue/urine frequency symptoms for patients with the lowest ECOG Performance Status , and borderline worse stool frequency scores from Types 5 and 6 patients on the Bristol Stool Scale.Conclusion: The study validated the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-CR29. The clinical applicability warrants further studies with greater number of participants.收起

文献类型

期刊